Spinal cord neoplasm
- ClinicalTrials.gov lists trials that are studying or have studied Spinal cord neoplasm. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
The FDA has approved this product to be used in this manner.
|Management of severe spasticity of spinal cord origin in patients who are unresponsive to oral baclofen therapy or experience intolerable CNS side effects at effective doses.|
|More Information about this product||
Drug Information Portal
Medline Plus Health Information